Ignite Creation Date:
2025-12-26 @ 2:42 PM
Ignite Modification Date:
2026-02-07 @ 10:26 PM
Study NCT ID:
NCT03872206
Status:
COMPLETED
Last Update Posted:
2024-06-07
First Post:
2019-03-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of HPN536 in Patients With Advanced Cancers Associated With Mesothelin Expression
Sponsor:
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-16
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-04
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-11
First Submit QC Date:
None
Study First Post Date:
2019-03-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-05
Last Update Post Date:
2024-06-07
Last Update Post Date Type:
ACTUAL